Cancer Antigen 125 (CA 125) Level
Test Codes
EPIC: LAB155, Beaker: CA125, Antrim: 30220
Department
Chemistry
Specimen Collection Criteria
Collect: One Gold-top SST tube. (Minimum Whole Blood: 2.0 mL)
Physician Office/Draw Specimen Preparation
Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Refrigerate (2-8°C or 36-46°F) the centrifuged collection tube within 2 hours of collection. (Minimum Serum: 0.5 mL)
Preparation for Courier Transport
Transport: Centrifuged collection tube, refrigerated (2-8°C or 36-46°F). (Minimum Serum: 0.5 mL)
Rejection Criteria
- Plasma specimens.
- Severely lipemic, icteric, or hemolyzed specimens.
In-Lab Processing
Let specimen clot 30-60 minutes then immediately centrifuge to separate serum from cells. Room temperature is acceptable for a maximum of 2 hours. Serum must be frozen (-20°C/-4°F or below) if not tested within 24 hours of collection. (Minimum Serum: 0.5 mL)
Storage
Specimen Stability for Testing:
Centrifuged SST Tubes and Microtainers® with Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): Unacceptable
Red-top Tubes and Microtainers® without Separator Gels
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): Unacceptable
Frozen (-20°C/-4°F or below): Unacceptable
Serum Specimens (Pour-Overs)
Room Temperature (20-26°C or 68-78.8°F): 2 hours
Refrigerated (2-8°C or 36-46°F): 7 days
Frozen (-20°C/-4°F or below): 2 months
Specimen Storage in Department Prior to Disposal:
Refrigerated (2-8°C or 36-46°F): 7 days
Laboratory
Dearborn Chemistry Laboratory
Royal Oak Automated Chemistry Laboratory
Performed
Monday – Friday.
Results available in 2 business days.
Reference Range
Less than or equal to 35 U/mL.
Test Methodology
Chemiluminescent Immunoassay.
Interpretation
Individuals receiving mouse immunoglobulin by parenteral routes may produce anti-mouse antibodies. Serum from such individuals may produce erroneous results. CA-125 assay should not be performed until at least three weeks after the completion of primary chemotherapy and at least two months after abdominal surgery as these procedures may affect the assay.
Half Life in Blood: 4.8 days.
Clinical Utility
Conditions that cause elevated CA 125 levels include: ovarian cancer, pregnancy, ovarian cysts, uterine leiomyomas, pelvic inflammatory disease, endometriosis and menstruation.
CA 125 is the most important tumor marker for the management of ovarian cancer. It is best used as an adjunct test with ultrasound or in combination with a second tumor marker test. Predictive values approach 100%, when it is added to other diagnostic tests in postmenopausal women. However, because of its lack of specificity, CA 125 is NOT recommended as a general screen for ovarian cancer.
Serial CA 125 measurements after surgical debulking and chemotherapy are useful as a prognostic indicator, and the rate of fall of CA 125 levels has a positive correlation with five year survival. Rising CA 125 level post-treatment can often occur before radiological evidence of recurrent disease by as much as 12 months (1).
Reference
- Orum DH, Jeyarajah AR. The role of ultrasound and tumor markers in the early detection of ovarian cancer. Bri J Obste Gynecol 1994; 101: 939-945.
CPT Codes
86304
LOINC: 10334-1
Contacts
Chemistry Laboratory – DBN
313-436-2196
Name: Chemistry Laboratory – DBN
Location:
Phone: 313-436-2196
Automated Chemistry Laboratory – RO
248-551-8065
Name: Automated Chemistry Laboratory – RO
Location:
Phone: 248-551-8065
Last Updated
10/17/2024
Microtainer® and Vacutainer® are registered trademarks of Becton, Dickinson and Company.
UroVysion® is a registered trademark of Abbott Laboratories. ThinPrep® is a registered trademark of Hologic, Incorporated.